Medicare Dual Eligible Prescription Drug Coverage Act of 2005

Bill: 109-hr-1144
Sponsor: Rep. Allen, Thomas H. [D-ME-1]
Introduced: 2005-03-08 in the House
Policy area: Health
Subjects: Commerce
Community health services
Congress
Congressional investigations
Congressional reporting requirements
Consumer education
Cost control
Drug utilization
Drugs
Economics and Public Finance
Federal aid to health facilities
Federal-state relations
Finance and Financial Sector
Government Operations and Politics
Government paperwork
Health counseling
Health insurance
Health maintenance organizations
Health surveys
Intergovernmental fiscal relations
Managed care
Medicaid
Medical records
Medical statistics
Medicare
Prescription pricing
Rebates
Social Welfare
Welfare eligibility

Summary:
action_date: 2005-03-08
text: 
Medicare Dual Eligible Prescription Drug Coverage Act of 2005 - Provides that, for prescriptions filled between January 1 and June 30, 2006, requirements for the coordination of prescription drug benefits with Medicare as primary payor for dual eligible individuals under the new prescription drug benefit program (PDP) under Medicare part E (Voluntary Prescription Drug Benefit Program) shall not apply. Requires a State to continue to provide Medicaid medical assistance with respect to prescription drugs as if such coordination requirements had not been enacted. 
 
Declares that no State or the District of Columbia shall be required to pay (reimburse) the Secretary of Health and Human Services for Medicaid prescription drug costs for dual eligible individuals (Medicaid clawback payments) for any month before July 1, 2006. 
 
Earmarks specified amounts for education and outreach to dual eligibles regarding prescription drug coverage and monitoring of their transition to prescription drug coverage under Medicare.
 
Requires a PDP sponsor and an MA organization offering an MA-PD plan to submit to the Secretary appropriate information regarding the drug utilization of enrollees in such plans who are full-benefit dual eligible individuals. Directs the Secretary to collect data on the drug utilization of full-benefit dual eligible individuals and share it with the States and District of Columbia in as close to a real-time basis as possible.
 
Directs the Comptroller General of the United States to study and report to Congress on the clawback formula.


Legislative actions:
action_date: 2005-03-15
text: Referred to the Subcommittee on Health.
action_date: 2005-03-14
text: Referred to the Subcommittee on Health.
action_date: 2005-03-08
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2005-03-08
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2005-03-08
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2005-03-08
text: Introduced in House
action_date: 2005-03-08
text: Introduced in House